KM Research Hub
← 返回论文库
已完成 入排:排除 图源:可得 入排置信度 0.96

Prognostic value of radiologic and pathological response in colorectal cancer liver metastases upon systemic induction treatment: subgroup analysis of the CAIRO5 trial.

M J G Bond, C Mijnals, K Bolhuis, M J van Amerongen, M R W Engelbrecht, J J Hermans, K P van Lienden, A M May, R-J Swijnenburg, C J A Punt

ESMO Open 9(12) 104075

PMID39667310
PMCIDPMC11697041
DOI10.1016/j.esmoop.2024.104075
发表日期2024-12-12
入排依据:属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。
摘要

摘要

BACKGROUND: RECIST may not be optimal for assessing treatment response with current systemic regimens. We evaluated RECIST, morphologic, and pathologically documented response (pathological response) in patients with initially unresectable colorectal cancer liver-only metastases (CRLM). PATIENTS AND METHODS: Four hundred and eighty-nine patients from the phase III CAIRO5 trial were included who were treated with FOLFOX/FOLFIRI/FOLFOXIRI and bevacizumab or panitumumab. The association of the different response tools with overall survival (OS) was evaluated for all patients, and with early recurrence (<6 months) for patients after complete local treatment. RESULTS: In the overall population, suboptimal [hazard ratio (HR) 1.10, 95% confidence interval (CI) 0.83-1.47] and optimal (HR 0.95, 95% CI 0.74-1.22) morphologic response were not associated with OS compared with no response. RECIST partial response (HR 0.61, 95% CI 0.49-0.76) and progressive disease (HR 5.77, 95% CI 3.97-8.39) were associated with OS compared with stable disease. In 242 patients who underwent local treatment, suboptimal (HR 1.22, 95% CI 0.76-1.96) and optimal (HR 1.28, 95% CI 0.89-1.86) morphologic response were not associated with OS compared with no response. RECIST partial response was not significantly associated with OS (HR 0.73, 95% CI 0.52-1.01), whereas progressive disease was (HR 19.74, 95% CI 5.75-67.78), compared with stable disease. While major pathological response (HR 0.66, 95% CI 0.44-0.99) was associated with OS, partial pathological response (HR 0.82, 95% CI 0.57-1.19) was not, compared with no pathological response. Pathological response, but not morphologic response and RECIST, was significantly associated with early recurrence (P < 0.001) which occurred in 13/58 (22%) patients with major response, 29/61 (48%) patients with partial response, and 51/88 (58%) patients with no response. CONCLUSIONS: Our results show that RECIST but not morphologic response was prognostic for OS. In patients eligible for local treatment, neither RECIST nor morphologic response were associated with early recurrence. Pathological response was associated with early recurrence but is only available post-operatively. Hence, novel preoperative parameters are warranted to predict early recurrence and prevent potentially futile liver surgery.

KM 提取结果

2 个 Figure · 5 个 KM 面板

进入结果中心
KM Figure2 个面板

Figure 2

Figure 2 Overall surviv al in all patients. Overall survival according to (A) best morphologic response and (B) best RECIST response. CI, confidence interval; HR, hazard ratio; OS, overall survival.

A

Overall survival

Figure 2 · Panel A

complete 待 EXE 对齐 预期 3 条 已提取 3 条

Panel A 是同一 Figure 2 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

查看结果
B

Overall survival

Figure 2 · Panel B

complete 待 EXE 对齐 预期 4 条 已提取 4 条

Panel B 是同一 Figure 2 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

质量提示曲线 4:extreme upward reversal
查看结果
KM Figure3 个面板

Figure 3

Figure 3 Overall survival in patients w ho underwent local treatment. Association of morphologic (A), RECIST (B), and pathological (C) response with overall survival in patients who underwent local treatment. CI, confidence interval; HR, hazard ratio; NA, not applicable; OS, overall survival.

A

overall survival

Figure 3 · Panel A

complete 待 EXE 对齐 预期 3 条 已提取 3 条

Panel A 是同一 Figure 3 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

查看结果
B

overall survival

Figure 3 · Panel B

complete 待 EXE 对齐 预期 3 条 已提取 3 条

Panel B 是同一 Figure 3 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

查看结果
C

overall survival

Figure 3 · Panel C

complete 待 EXE 对齐 预期 3 条 已提取 3 条

Panel C 是同一 Figure 3 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。

查看结果
其他 Figure(2,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

Figure 1Figure 1 Flowchart of eligible patients.
非 KM Figure
Figure 4Figure 4 Early recurrence in patients who underwent complete local treatment. Association of morphologic, RECIST, and pathological response with early recurrence (A) and early recurrence without salvage local treatment (B) in patients who underwent complete local treatment.
非 KM Figure